Clinical Trial Update: Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety and tolerability of the radiopharmaceutical 212Pb-DOTAM-GRPR1 in adults with recurrent or metastatic GRPR-ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Cervical Cancer
• Colon Cancer
• Glioblastoma
• Non-small Cell Lung Cancer

Drugs mentioned

• 212Pb-DOTAM-GRPR1

Snippet

Sponsor: Orano Med LLC | Conditions: Cervical Cancer, Breast Cancer | Phase 1 | Status: RECRUITING